ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology.
Align Technology, a manufacturer of 3D digital scanners and founder of the orthodontic brand Invisalign, has filed a patent infringement suit against rival company 3Shape.
France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.
The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Global pharmaceutical company Eli Lilly has entered into a licence and collaboration agreement with Swiss biotechnology company AC Immune.
Pharmaceutical company AstraZeneca and charity Cancer Research UK have announced that they will launch a centre to accelerate the discovery of new cancer treatments.
UK-based biotech company Silence Therapeutics has settled a patent dispute and entered into a licence agreement with Alnylam Pharmaceuticals.
The US Court of Appeals for the Federal Circuit partly reversed, vacated, and remanded a US International Trade Commission decision in a trade dress dispute on Friday, December 7.
The US Court of Appeals for the Federal Circuit has reversed one decision and affirmed another in two cases involving Novartis, with both judgments delivering victory to the Swiss pharmaceutical company.
Six organisations have appealed against the European Patent Office’s decision to uphold a patent for a key hepatitis C drug.